About Penses
Penses is a company based in Seoul (South Korea) founded in 2015. Penses offers products and services including Cultivated Meat and Bio-Printing Technology. Penses operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.
- Headquarter Seoul, South Korea
- SectorsHealthcare
- Phone•••• ••••
- Website pensees.co.kr
- Social LinkedIn
- Legal Name Pangse Co., Ltd.
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Penses
Penses operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Penses
Penses offers a comprehensive portfolio of products and services, including Cultivated Meat and Bio-Printing Technology.
Lab-grown meat using bio-printing for sustainable and ethical consumption.
Advanced 3D printing for creating meat alternatives from animal cells.
Competitors of Penses
Penses operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| missionbio.com | 2014 | San Francisco, United States | $110M | 109 | Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. | |
| cellares.com | 2019 | San Francisco, United States | $355M | – | Medical devices for cell-based therapy manufacturing are produced. | |
| lumicks.com | 2014 | Amsterdam, Netherlands | $93.38M | – | Optical tweezers instruments for single-molecule analysis are manufactured. | |
| xcellbio.com | 2012 | San Francisco, United States | $40.9M | 11 | Cell culture analysis devices for cancer research are developed. | |
| levitasbio.com | 2017 | San Francisco, United States | $73.77M | – | Single-cell imaging platform developed via magnetic levitation technology. | |
| spherefluidics.com | 2010 | Cambridge, United Kingdom | $56.67M | 29 | Single-cell analysis systems are developed for biologics discovery. | |
| bionautlabs.com | 2015 | Los Angeles, United States | $63.2M | – | Miniature robots are developed for targeted drug delivery applications. | |
| atrandi.com | 2016 | Vilnius, Lithuania | $31.01M | – | Microfluidic solutions for life sciences and single-cell analysis are developed. |
Detailed competitors of Penses
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Penses
The website of Penses (pensees.co.kr) receives about 2.7K visits a month.
- Monthly visits2.7K
▼ 7.8% vs previous month
Similar companies to Penses
10 companies that operate in the same segment as Penses (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Penses
Penses was founded in 2015.
Penses is headquartered in Seoul, South Korea.
The company was founded in 2015 in Seoul, South Korea, within the biotechnology sector. 3D cell analysis devices are produced for research and medical applications. Products such as the Vitarix W Bioprinter and a 3D arm spheroid model are offered, supporting tissue analysis, disease diagnosis, and 3D cell culture evaluation. Operations focus on innovative tools for cellular experimentation in laboratory settings.
Penses's top competitors include 10X Genomics, Mission Bio and Cellares.
Penses offers Cultivated Meat and Bio-Printing Technology.
Penses operates through ,.